Cost of illness in Italian women with Luts followed at urology centres:the flow study

Autor: Sgarbi S. ,Rizzi CA, Santini AM, Zattoni F., Pesce F., Scarpa R.M., Tubaro A, Artibani W., PREZIOSO, DOMENICO

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3730::f7277e66808c05803f485e41bf4520dc
http://hdl.handle.net/11588/565198

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.

Autor: Swaney, JS, Chapman, C, Correa, LD, Stebbins, KJ, Bundey, RA, Prodanovich, PC, Fagan, P, Baccei, CS, Santini, AM, Hutchinson, JH, Seiders, TJ, Parr, TA, Prasit, P, Evans, JF, Lorrain, DS, Swaney, J S, Correa, L D, Stebbins, K J, Bundey, R A, Prodanovich, P C

Publikováno v: British Journal of Pharmacology; Aug2010, Vol. 160 Issue 7, p1699-1713, 15p

Italian validation of the urogenital distress inventory and its application in LUTS patients

Autor: Domenico Prezioso, Andrea Tubaro, Walter Artibani, Ambra M. Santini, Filiberto Zattoni, C.A. Rizzi, Lucia Simoni, Roberto Mario Scarpa, Francesco Pesce

Publikováno v: European urology. 50(6)

Objectives The objective of this study was to validate the Italian version of the Urogenital Distress Inventory (UDI) in a sample of women with lower urinary tract symptoms (LUTS). Methods The linguistic validation of the questionnaire was performed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e46522e42f58a04918b02f097b7c4ea6
https://pubmed.ncbi.nlm.nih.gov/16713067

Author Correction: JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disorders.

Autor: Ambrus-Aikelin G; Jecure Therapeutics, San Diego, CA, USA., Takeda K; Department of Pediatrics, National Jewish Health, Denver, CO, USA., Joetham A; Department of Pediatrics, National Jewish Health, Denver, CO, USA., Lazic M; Jecure Therapeutics, San Diego, CA, USA., Povero D; Jecure Therapeutics, San Diego, CA, USA. povero.davide@mayo.edu.; Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA. povero.davide@mayo.edu., Santini AM; Jecure Therapeutics, San Diego, CA, USA., Pranadinata R; Jecure Therapeutics, San Diego, CA, USA., Johnson CD; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA., McGeough MD; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA., Beasley FC; Jecure Therapeutics, San Diego, CA, USA., Stansfield R; Jecure Therapeutics, San Diego, CA, USA., McBride C; Jecure Therapeutics, San Diego, CA, USA., Trzoss L; Jecure Therapeutics, San Diego, CA, USA., Hoffman HM; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA., Feldstein AE; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA., Stafford JA; Jecure Therapeutics, San Diego, CA, USA., Veal JM; Jecure Therapeutics, San Diego, CA, USA., Bain G; Jecure Therapeutics, San Diego, CA, USA., Gelfand EW; Department of Pediatrics, National Jewish Health, Denver, CO, USA.

Publikováno v: Scientific reports [Sci Rep] 2023 Nov 16; Vol. 13 (1), pp. 20081. Date of Electronic Publication: 2023 Nov 16.